Simpson for president





































Actually the portfolio of products is good. Poor management has always kept it weak.

They are products that don't generate much revenue, certainly not anywhere near the cost invested in them. Small bone's largest grossing product is STAR ankle and that only does on average of $15 million a year.

For ANY deal to go through Small Bone is going to have to sell at a HUGE loss to its investors.
 






They are products that don't generate much revenue, certainly not anywhere near the cost invested in them. Small bone's largest grossing product is STAR ankle and that only does on average of $15 million a year.

For ANY deal to go through Small Bone is going to have to sell at a HUGE loss to its investors.

What about the stock options?